| Particulars |
| Company Name |
Marksans Pharma Ltd |
| Face Value |
1 |
| BSE Code |
524404 |
| Year End |
202603 |
| Full Year |
| Equity (Rs in Cr.) |
45.32 |
| B.V. Rs |
36.50 |
| Sales Rs in Cr. |
1,341.48 |
| NP Rs in Cr. |
299.27 |
| NP Var% |
60.00 |
| Div% |
90.00 |
| CPS Rs |
7.40 |
| EPS Rs |
6.60 |
| Traded Value(Rs in Lakhs) |
3,552.47 |
| 52 Week High |
337.00 |
| 52 Week Low |
156.00 |
| Price BSE |
333.00 |
| Price NSE |
333.00 |
| Market Capital(Rs in Cr.) |
15,090.35 |
| P/C Ratio |
45.20 |
| P/E Ratio |
50.40 |
| Price Vs.BV |
9.12 |
| Latest Quarter |
| Year End |
202606 |
| Sales Rs in Cr. |
321.19 |
| NP Rs in Cr. |
69.04 |
| NP Var % |
44.00 |
| Trailing Twelve Months |
| Year End |
202606 |
| Sales |
1,029.71 |
| OPM |
16.45 |
| NP |
153.50 |
| NP Var% |
57.44 |
| EPS |
7.10 |
| PE |
46.90 |
|